# Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

> **NCT05593588** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Avni Joshi** · enrollment: 20 (estimated)

## Conditions studied

- Common Variable Immunodeficiency
- Interstitial Lung Disease Due to Systemic Disease

## Interventions

- **DRUG:** Fisetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05593588
- **Lead sponsor:** Avni Joshi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-04-12
- **Primary completion:** 2026-05
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05593588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05593588, "Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05593588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*